Our Story

The resilience, agility and shared values of our people has seen us thrive despite the highly competitive and challenging business environment we operate in.

We have set ourselves an ambitious five-year corporate goal to be the ‘go to partner’ when commercialising complex medicines in European hospitals, and I am confident we will achieve this as a united and committed team. Graeme Duncan, CEO

Welcome to ADVANZ PHARMA, a specialty pharmaceutical company with a strategic focus on complex medicines in Europe that is committed to improving the lives of patients by enhancing the critical medicines they depend on.

We could not do this without the resilience and entrepreneurial

spirit of our people, the successful collaboration with our

partners, and intrinsic guidance of our values to help us achieve

our purpose while becoming a truly dynamic, progressive

company in the process.

Introduction

Graeme Duncan,

CEO

Global Teams Openness

Decision Making

Entrepreneurial

Integrity

Our purpose is simple – to improve the lives of patients

by enhancing the critical medicines they depend on,

broadening patient access and optimising health outcomes.

Our Purpose

Our Goal To become the ‘go to partner’ when commercialising

complex medicines in European hospitals.

Our ValuesOur values reflect who we are and what we stand for.

Having a purpose, goal and values would mean nothing,

however, if we didn’t have the people to bring them to life,

to share the journey and vision of building a company we

believe in. From London to Mumbai, Helsingborg to Sydney

and Geneva to Chicago, resilience and common values

have united ADVANZ PHARMA, regardless of geography

or remote working situation.

Who We Are?

ADVANZ PHARMA is a specialty pharmaceutical company with a strategic focus on complex medicines in Europe that is committed to improving the lives of patients by enhancing the critical medicines they depend on.

With the agility of a virtual business but the reassurance that

comes with a heritage spanning decades, smart thinking,

innovation and a passion for enhancing medicines to broaden

access and improve patient health outcomes is at the heart

of our business. This is reflected in the work we do, how we

do it and the people who deliver it.

As the go to partner for commercialising complex medicines

in European hospitals, our highly responsive and experienced

teams in marketing, direct sales, market access and medical

work across major European markets to broaden access,

choice and availability while our established products business

with its portfolio of more than 180 molecules provides essential

medicines globally to the patients that need them.

ADVANZ PHARMA has an operational headquarters in

London, an operations centre of excellence in Mumbai,

offices in Geneva and Paris and commercial affiliates in

North America, Europe and Australia/NZ, together with an

established global network of commercial partners throughout

the rest of the world.

The success of any company is driven by its people. We are no different.

Our teams are made up of people who come from all walks

of life and backgrounds, and thrive in an environment where

diversity is celebrated but where we are all united by the same

passion, to help improve the lives of patients by enhancing

the critical medicines they depend on.

Our lean and virtual model combined with our responsive

and highly experienced teams mean that we are ready to be

flexible and adapt to changing situations at a moment’s notice.

As a company, we are proud to say we are small enough

to care but big enough to make a difference.

Furthermore, ADVANZ PHARMA is committed to investing

in the growth of our people and rewarding and recognising

the contribution they make while providing a unique culture

that includes a collaborative and flexible working environment

– our people are encouraged to work up to 3 days a week

remotely, helping them operate at the very best of their ability

while ensuring work life balance.

Our People

ADVANZ PHARMA is committed to improving patients’ lives by enhancing the critical medicines they depend on. We do this through two distinct business divisions:

– Expanding European Strategic Growth Business

Focused on developing and commercialising complex

medicines in the European hospitals market.

– Leading, global Established Products Business

Diversified portfolio of established medicines with decades

of prescription history and proven performance.

Our Business

Both divisions are underpinned by our virtual and lean

operating, our leading operations centre of excellence in

Mumbai, and our global office locations, providing medical,

regulatory, quality and supply-chain capabilities supporting

almost 100 countries. It means we are able to acquire and

integrate new products and companies quickly and efficiently

and are always on the lookout for products that fit our strategic

focus so that we can continue to expand and provide clear

value to patients and healthcare providers.

Primed for scalability

Our Portfolio

At ADVANZ PHARMA, our European hospital portfolio of complex medicines focuses on Anti-infectives, Endocrinology and Critical Care medicines.

This is bolstered by an established brands business unit of

more than 180 molecules sold into 100 countries across a

wide range of therapy areas such as CVD, pain management,

ophthalmology, urology, and central nervous system disorders.

Over the years, we have successfully expanded our portfolio

through targeted licensing and acquisitions and are well

positioned for growth. We continue to work closely with

our partners to enhance our medicines and add value

through innovation, particularly in the anti-infectives space

which has had limited investment in recent years, despite

the ever-increasing health burden of antimicrobial resistance.

Our focus on complex medicines means building a portfolio of hospital specific products, and enhanced commercial and medical capabilities, in key therapeutic areas such as anti-infectives and endocrinology that bring innovation to improve patient access and health outcomes. Paul Burden, Chief Commercial Officer, Strategic Growth Business

Our Partners

ADVANZ PHARMA is committed to improving the lives of patients by enhancing the critical medicines they depend on.

Partnerships are a fundamental part of this, and are vital

to creating new, lasting relationships, where we can continue

to invest significantly in products to help broaden patient

access and health outcomes.

– Close working relationships As highly experienced teams with significant commercial and

medical knowledge, we pride ourselves on our close working

relationships with manufacturers, distributors and healthcare

professionals – something we are very much looking to build

upon as we continue to grow the business in Europe.

– Seeking partnerships We are constantly on the lookout for products that fit our

strategic focus and channel expertise, that provide clear value

to patients and healthcare providers.

Why partner with us?

– Proud heritage and successful track record We have a proud heritage and successful track record of

business and product acquisitions. Most recently we completed

the acquisition of a portfolio of Alprostadil products from

UCB and acquired Correvio Pharma in 2020, increasing our

European presence, strengthening our positioning as a trusted

partner when commercialising hospital medicines in Europe

together with establishing a robust foundation to continue our

growth trajectory.

– Actively on the lookout for new growth drivers We continue to invest in our pipeline and aim to add

considerably to our portfolio of complex medicines over

the next few years with the launch of promising pipeline

assets in 2021 and beyond.

Our Supply Chain

It goes without saying that the Covid-19 pandemic brought immense pressure to our industry.

Here at ADVANZ PHARMA, we have not wavered on our

commitment to deliver essential medicines to those who need

them. ADVANZ PHARMA has invested heavily in improving

supply continuity, keeping above industry-average inventory

levels and having dual sourced supply on critical products

which has been crucial during the pandemic.

Many of our medicines are used in intensive care units around

the world, whilst others treat chronic conditions that don’t

go away simply because the world’s attention is elsewhere –

so ensuring continued supply and access has always been

our primary aim.

A crucial part of this sustained supply and resilience is our

focus on collaboration and connectivity with our cross-industry

partner network. By keeping a close and proactive dialogue

with production lines, manufacturers and shipping – as well

as working around the clock – we are able to successfully

maintain the supply of critical medicines.

In recent times, we saw our model being tested as demand

for certain medicines surged, putting pressure on our systems,

yet it passed with flying colours as we continued to provide

medicines despite the challenges thrown at it, ensuring patients

got the medicines they needed.

Our Social Responsibility

Driven by our purpose and values, we take an active approach to charitable work, helping communities at grass roots and encouraging our people to do likewise in their personal lives.

We support SOS Children’s Villages UK, part of the world’s

largest charity protecting children who have lost parental

care. We also support Snehasadan, a charity in India offering

support, a home, education and a future to homeless children.

Recently, we raised funds won their behalf to rebuild a

children’s home near our Mumbai office.

We donate medicine for hard-to-reach and disaster-hit

communities through International Health Partners, Europe’s

largest coordinator of donated medicines, supporting patients

around the world who cannot otherwise access the medicines

they need, reinforcing our purpose of not letting people go

without treatment.

Supporting communities in crisisAlongside our on-going commitments is a desire to respond

to crisis situations, an example of which was our 24-hour dance-

a-thon where employees around the world, beginning on the

east coast of Australia and ending in the Asia Pacific region,

danced around-the-clock to raise tens of thousands of pounds

for The British Red Cross Global Coronavirus Fund, an activity

which encapsulates the spirit of our people.

About Advanz Pharma

ADVANZ PHARMA is a specialty pharmaceutical company

with a strategic focus on complex medicines in Europe that

is committed to improving the lives of patients by enhancing

the critical medicines they depend on.

We leverage our agile and experienced team to innovate

and enhance the critical medicines patients depend on,

broadening patient access and improving health outcomes.

With deep expertise in Anti-Infectives, Endocrinology and

Critical Care, ADVANZ PHARMA is the go-to-partner when

commercialising complex medicines in European hospitals.